You are here

  • Home
  • Archive
  • Volume 73, Issue 1
  • Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1

Citation Tools

Article menu
Clinical and epidemiological research
Extended report
Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Sieper J, Lenaerts J, Wollenhaupt J, et al
Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1
Annals of the Rheumatic Diseases 2014;73:101-107.